FSD Pharma (HUGE) - כסף מזומן למניה

Cash per share data on the GURU.Markets portal demonstrates the financial stability of FSD Pharma Inc. (HUGE), where 0.05 captures the current state of this parameter. The issuer is implementing ESG principles by reducing laboratory waste and strictly adhering to bioethics. Formula development and clinical trials have been outsourced to external contractors, while process automation is being deployed through robotic screening and software-based data array processing.
פילוחים אנליטיים של חברת FSD Pharma Inc.

FSD Pharma Inc. operates in the R&D sector, where primary capital is allocated toward drug development. This metric determines the amount of available liquidity per share, reflecting the actual cash reserve. For biopharmaceuticals, this is a critical survival indicator in conditions of negative cash flow. It is essential for investors to track the burn rate until the formulas are patented. By analyzing the free liquidity per share, one can assess the company's time horizon for autonomy.